COVID‐19 vaccination in patients with multiple myeloma: Focus on immune response

Abstract

First Department of Medicine, Clinic Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria CIMA, IDISNA, CIBERONC, Clínica Universidad de Navarra, Pamplona, Spain Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Erasmus MC Cancer Institute, Erasmus University of Rotterdam, Rotterdam, The Netherlands IBSAL, Cancer Research Center, University Hospital of Salamanca, Salamanca, Spain Department of Hematology, University Hospital Nantes, Nantes, France Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece